Acute vasoreactivity testing in pediatric idiopathic pulmonary arterial hypertension: an international survey on current practice
暂无分享,去创建一个
J. Feinstein | A. Lopes | Parag Barward | D. Ivy | S. Abman | R. Hopper | I. Adatia | J. Fineman | U. Krishnan | E. Rosenzweig | S. Moledina | T. Kashour | R. Berger | Omar Al-Tamimi | S. Handler | P. Bobhate | M. J. Cerro | Gabriel F Diaz | L. Caicedo | A. Mendoza | Humberto Garcia Aguilar | Dora Haag | T. Humpl | Manoj Kumar Rahit | C. Labrandero de Lera | Humberto García Aguilar | Stephanie S. Handler
[1] D. Ivy,et al. Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management , 2019, European Respiratory Journal.
[2] G. Hansmann,et al. Executive summary. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK , 2016, Heart.
[3] G. Hansmann,et al. Diagnostics, monitoring and outpatient care in children with suspected pulmonary hypertension/paediatric pulmonary hypertensive vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network , 2016, Heart.
[4] G. Hansmann,et al. Hemodynamic assessment and acute pulmonary vasoreactivity testing in the evaluation of children with pulmonary vascular disease. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISH , 2016, Heart.
[5] D. Ivy,et al. Acute Vasodilator Response in Pediatric Pulmonary Arterial Hypertension: Current Clinical Practice From the TOPP Registry. , 2016, Journal of the American College of Cardiology.
[6] S. Harikrishnan,et al. Cardiac Catheterization in Children with Pulmonary Hypertensive Vascular Disease: Consensus Statement from the Pulmonary Vascular Research Institute, Pediatric and Congenital Heart Disease Task Forces , 2016, Pulmonary circulation.
[7] Simon Gibbs,et al. 2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.
[8] W. Chung,et al. Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society , 2015, Circulation.
[9] M. Judson,et al. The role of calcium channel blockers for the treatment of pulmonary arterial hypertension: How much do we actually know and how could they be positioned today? , 2015, Respiratory medicine.
[10] H. Hillege,et al. Prognostic factors in pediatric pulmonary arterial hypertension: A systematic review and meta-analysis. , 2015, International journal of cardiology.
[11] S. Rich,et al. Peripheral Blood Signature of Vasodilator-Responsive Pulmonary Arterial Hypertension , 2015, Circulation.
[12] A. Galdó,et al. Assessing Pulmonary Hypertensive Vascular Disease in Childhood. Data from the Spanish Registry , 2014 .
[13] W. Seeger,et al. Updated treatment algorithm of pulmonary arterial hypertension. , 2013, Journal of the American College of Cardiology.
[14] Angelo Branzi,et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. , 2014, European heart journal.
[15] W. Seeger,et al. Algorithm of Pulmonary Arterial Hypertension , 2022 .
[16] T. Fleming,et al. Pediatric pulmonary hypertension. , 2013, Journal of the American College of Cardiology.
[17] H. Hillege,et al. Acute pulmonary vasodilator response in paediatric and adult pulmonary arterial hypertension: occurrence and prognostic value when comparing three response criteria. , 2011, European heart journal.
[18] R. Barst,et al. Survival in Childhood Pulmonary Arterial Hypertension: Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management , 2011, Circulation.
[19] I. Schulze-Neick,et al. Childhood idiopathic pulmonary arterial hypertension: a national cohort study , 2010, Heart.
[20] C. Dauphin,et al. Characteristics and prospective 2-year follow-up of children with pulmonary arterial hypertension in France. , 2010, Archives of cardiovascular diseases.
[21] M. Humbert,et al. Long-Term Response to Calcium Channel Blockers in Idiopathic Pulmonary Arterial Hypertension , 2005, Circulation.
[22] A. Torbicki,et al. Diagnosis and differential assessment of pulmonary arterial hypertension. , 2004, Journal of the American College of Cardiology.
[23] G. Maislin,et al. Vasodilator therapy for primary pulmonary hypertension in children. , 1999, Circulation.
[24] S. Rich,et al. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. , 1992, The New England journal of medicine.
[25] B. Brundage,et al. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. , 1987, Circulation.
[26] B. Brundage,et al. The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension. , 1985, Circulation.
[27] Simon Gibbs,et al. [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.
[28] A. Sabaté Rotés,et al. Assessing pulmonary hypertensive vascular disease in childhood. Data from the Spanish registry. , 2014, American journal of respiratory and critical care medicine.